Share this video  

VJOncology is committed to improving our service to you

GU Cancers 2020 | Kidney cancer: MK-6482 & sitravatinib with nivolumab

Daniel Geynisman, MD, Fox Chase Cancer Center, Philadelphia, PA, discusses novel combinations in renal cell cancers, specifically focusing on studies of MK-6482 and sitravatinib with nivolumab. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter